Title : Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C3.

Pub. Date : 2019 Apr 1

PMID : 30703376






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Buparlisib exhibited the strongest inhibitory effect on recombinant AKR1C3, with a half-maximal inhibitory concentration (IC50) of 9.5 muM. NVP-BKM120 latexin Homo sapiens